EUVIMEDEUVIMED entdecken
Crossref

Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer

Malkiet Kaur, Manju Nagpal, Balraj Saini, Thakur Gurjeet Singh, Manjinder Singh, Geeta Aggarwal, Gitika Arora Dhingra

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (19s)

DOI: 10.25258/ijddt.16.19s.65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Malkiet Kaur und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diclofenac, generally used as a non-steroidal anti-inflammatory drug (NSAID), is effective in treating pain and inflammatory conditions but causes gastrointestinal and renal side effects upon oral administration. This study aims to develop and evaluate a transdermal microemulsion formulation of diclofenac using piperine as a bioenhancer, leading to enhanced drug permeability and therapeutic efficacy.

Methods

Pseudo-ternary phase diagrams were formed by using oleic acid (oil phase), Cremophor RH40 (surfactant), and Transcutol (co-surfactant). Optimized microemulsions were assessed for particle size, zeta potential, in vitro release studies of drug, ex vivo permeation and in vivo studies, including drug pharmacokinetics. Scanning electron microscopy (SEM) studies were carried out to assess skin permeability.

Results

Optimized microemulsions exhibited high clarity (transmittance >90%) and nano-sized droplets (A4: 11.41 nm, B1: 12.16 nm). In vitro studies showed A4 released 60% of the drug in 4 hours, while B1 took 6 hours, indicating both immediate and sustained release potential. Ex vivo studies confirmed enhanced drug permeation, with 80% release from A4-based gel and 76% from B1-based gel in 24 hours. SEM studies revealed an increase in skin porosity in the microemulsion, which may be due to the inclusion of piperine. In vivo studies confirmed sustained plasma drug levels with the piperine-enhanced formulation.

Conclusion

The diclofenac-piperine microemulsion gel demonstrated enhanced transdermal absorption, sustained drug release, and reduced systemic toxicity. It offers a promising alternative to oral diclofenac for safer and more effective pain management.

Zitieren

APA

Kaur, M., Nagpal, M., Saini, B., Singh, T. G., Singh, M., Aggarwal, G., & Dhingra, G. A. (2026). Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.65

Vancouver

Kaur M, Nagpal M, Saini B, Singh TG, Singh M, Aggarwal G, et al. Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.65

BibTeX
@article{Kaur2026,
  author = {Kaur, Malkiet and Nagpal, Manju and Saini, Balraj and Singh, Thakur Gurjeet and Singh, Manjinder and Aggarwal, Geeta and Dhingra, Gitika Arora},
  title = {Development and Evaluation of Diclofenac Microemulsion Formulation using Piperine as a Bioenhancer},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {19s},
  doi = {10.25258/ijddt.16.19s.65}
}
Kostenlos starten →